Critic at Large

» science policy and funding

Most Recent

image: The Great Divide

The Great Divide

By | December 1, 2013

A two-way bridge between science and policy is desperately needed.

2 Comments

image: Proceed with Caution

Proceed with Caution

By | October 1, 2013

While genomic data sharing is essential for research, scientists must work to keep sensitive, potentially damaging information under wraps.

1 Comment

image: Border Buffers

Border Buffers

By | April 1, 2013

Protected areas help to conserve imperiled tropical forests, but many are struggling to sustain their resident species.

0 Comments

image: DIYbio: Low Risk, High Potential

DIYbio: Low Risk, High Potential

By | March 1, 2013

Citizen scientists can inspire innovation and advance science education—and they are proving adept at self-policing.

5 Comments

image: Regulating Amateurs

Regulating Amateurs

By | March 1, 2013

How should the government ensure the safety and responsibility of do-it-yourself biologists?

2 Comments

image: Medicines for the World

Medicines for the World

By | October 1, 2012

A global R&D treaty could boost innovation and improve the health of the world’s poor—and rich.

0 Comments

image: Science and Democracy

Science and Democracy

By | October 1, 2012

Researchers and conscientious citizens must unite against the partisan rancor in American politics and restore the role of scientific information in policymaking.

1 Comment

image: Food for Thought

Food for Thought

By | June 1, 2012

Plant research remains grossly underfunded, despite the demand for increased crop production to support a growing population.

6 Comments

image: Hard and Harder

Hard and Harder

By | June 5, 2011

The path to eradicating malaria in Africa involves much more than just a vaccine.

18 Comments

image: Another Revolution Needed?

Another Revolution Needed?

By | March 1, 2011

Counting the many plagues that threaten research in the Middle East and North Africa region

1 Comment

Popular Now

  1. Consilience, Episode 3: Cancer, Obscured
  2. RNAi’s Future in Drug-Target Screening
    News Analysis RNAi’s Future in Drug-Target Screening

    A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

  3. A History of Screening for Natural Products to Fight Cancer
  4. Human Cord Plasma Protein Boosts Cognitive Function in Older Mice
AAAS